Evaluation of Biomarkers of NAFLD in a Cohort of Morbidly Obese Patients.
about
Novel algorithm for non-invasive assessment of fibrosis in NAFLDNLRP3 inflammasome activation is required for fibrosis development in NAFLD.The Wide and Complex Field of NAFLD Biomarker Research: Trends.Fetuin-A mRNA expression is elevated in NASH compared with NAFL patients.Free fatty acids repress small heterodimer partner (SHP) activation and adiponectin counteracts bile acid-induced liver injury in superobese patients with nonalcoholic steatohepatitis.Investigating Molecular Connections of Non-alcoholic Fatty Liver Disease with Associated Pathological Conditions in West Virginia for Biomarker Analysis.SPARC expression is associated with hepatic injury in rodents and humans with non-alcoholic fatty liver disease.Effects of resveratrol, exercises and their combination on gene expression and apoptosis in the liver of elderly rats with nonalcoholic fatty liver
P2860
Q28289982-CA049EF8-F6C7-4158-8704-7C08586FA8DCQ35146713-670651B3-63A9-4BB4-9DA8-8AD6F259FAA7Q36962085-F3EA2319-8F29-4EA6-82B7-D7A8509B2536Q44561660-006C9810-9B3B-4FE0-B02B-4AB7A8AF478EQ44697151-155C8398-08CB-4BC1-8A22-38C99F967C2EQ45305677-66CDBAB8-0D99-4514-BF0C-DA04EF3E4D04Q49287362-9CD44451-9855-4B31-A600-3B6BDA8F35DDQ58754705-6CAA0102-D1C8-4B7A-B634-B3901BB31889
P2860
Evaluation of Biomarkers of NAFLD in a Cohort of Morbidly Obese Patients.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Evaluation of Biomarkers of NAFLD in a Cohort of Morbidly Obese Patients.
@ast
Evaluation of Biomarkers of NAFLD in a Cohort of Morbidly Obese Patients.
@en
type
label
Evaluation of Biomarkers of NAFLD in a Cohort of Morbidly Obese Patients.
@ast
Evaluation of Biomarkers of NAFLD in a Cohort of Morbidly Obese Patients.
@en
prefLabel
Evaluation of Biomarkers of NAFLD in a Cohort of Morbidly Obese Patients.
@ast
Evaluation of Biomarkers of NAFLD in a Cohort of Morbidly Obese Patients.
@en
P2093
P2860
P50
P356
P1476
Evaluation of Biomarkers of NAFLD in a Cohort of Morbidly Obese Patients.
@en
P2093
Hagen Kälsch
Jochen Erhard
Julia Kälsch
Martin Schlattjan
P2860
P304
P356
10.1155/2011/369168
P577
2011-06-23T00:00:00Z